Megan Merlo – Page 2 – Clinical Trial Results

Dr. Mitchell Silver, Dr. Jay Giri, and Dr. C. Michael Gibson Discuss: Outcomes in High-risk Pulmonary Embolism Patients Undergoing FlowTriever Mechanical Thrombectomy: Results From The FLAME Study

March 5, 2023

Disclosures: TBD

Dr. John Forrest and Dr. C. Michael Gibson Discuss: Transcatheter Versus Surgical Aortic Valve Replacement In Aortic Stenosis Patients At Low Surgical Risk: 3-year Outcomes From The Evolut Low Risk Trial

March 5, 2023

Disclosures: TBD

Dr. Javed Bulter, Dr. Rasha Al-Lamee and Dr. C. Michael Gibson Discuss: ACC 2023 ACCess Points Daily Wrap-up – March 4, 2023

March 4, 2023

This Week in Medicine®: Dr. Kausik Ray and Dr. C. Michael Gibson Discuss: Review of the Year in Prevention and Lipids

December 27, 2022

Listen to Podcast Disclosures: TBD

Dr. Dominick Angiolillo and Dr. C. Michael Gibson Discuss: Aspirin Monotherapy versus Thiopyridine Therapy – Do We Have All The Answers Given There is a New Generation of Aspirin

September 19, 2022

Disclosures: TBD

Dr. Bryon Cryer and Dr. C. Michael Gibson Discuss: Gastrointestinal Toxicity of Aspirin: the Pathophysiology of the Problem and the Pathophysiologically Guided Solution

August 23, 2022

Disclosures: TBD

Dr. Jonathan Reiner and Dr. C. Michael Gibson Discuss: What the Best Path Forward for the CDC Might Look Like

August 18, 2022

Disclosures: TBD

Dr. C. Michael Gibson Presents: Secondary Prevention with Aspirin – Learn about the Latest FDA Approved Aspirin Formulation View

July 21, 2022

Disclosures: Consultant to PLx Pharma Inc.

Aspirin Therapy in 2022: New Horizons

May 2, 2022

A CME-Jointly Accredited Program This activity is supported by an independent educational grant from PLx Pharma Inc.

Dr. Andrew Althouse and Dr. C. Michael Gibson Discuss: Demystifying the Win Ratio

April 7, 2022

Disclosures: TBD